Nectar Lifesciences Statistics

Total Valuation

NSE:NECLIFE has a market cap or net worth of INR 4.02 billion. The enterprise value is 9.64 billion.

Market Cap	4.02B
Enterprise Value	9.64B

Important Dates

The last earnings date was Monday, July 7, 2025.

Earnings Date	Jul 7, 2025
Ex-Dividend Date	n/a

Share Statistics

NSE:NECLIFE has 224.26 million shares outstanding. The number of shares has decreased by -0.02% in one year.

Current Share Class	224.26M
Shares Outstanding	224.26M
Shares Change (YoY)	-0.02%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	48.73%
Owned by Institutions (%)	0.01%
Float	112.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.24
PB Ratio	0.42
P/TBV Ratio	0.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.48
EV / Sales	0.58
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	7.68

Financial Position

The company has a current ratio of 1.21, with a Debt / Equity ratio of 0.61.

Current Ratio	1.21
Quick Ratio	0.36
Debt / Equity	0.61
Debt / EBITDA	n/a
Debt / FCF	4.63
Interest Coverage	-1.19

Financial Efficiency

Return on equity (ROE) is -11.23% and return on invested capital (ROIC) is -3.42%.

Return on Equity (ROE)	-11.23%
Return on Assets (ROA)	-2.62%
Return on Invested Capital (ROIC)	-3.42%
Return on Capital Employed (ROCE)	-8.66%
Revenue Per Employee	9.90M
Profits Per Employee	-674,263
Employee Count	1,686
Asset Turnover	0.79
Inventory Turnover	1.87

Taxes

Income Tax	-478.53M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.43% in the last 52 weeks. The beta is 0.56, so NSE:NECLIFE's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	-36.43%
50-Day Moving Average	22.89
200-Day Moving Average	30.61
Relative Strength Index (RSI)	39.66
Average Volume (20 Days)	6,466,691

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:NECLIFE had revenue of INR 16.70 billion and -1.14 billion in losses. Loss per share was -5.07.

Revenue	16.70B
Gross Profit	3.02B
Operating Income	-888.47M
Pretax Income	-1.62B
Net Income	-1.14B
EBITDA	-264.57M
EBIT	-888.47M
Loss Per Share	-5.07

Full Income Statement

Balance Sheet

The company has 197.51 million in cash and 5.82 billion in debt, giving a net cash position of -5.62 billion or -25.07 per share.

Cash & Cash Equivalents	197.51M
Total Debt	5.82B
Net Cash	-5.62B
Net Cash Per Share	-25.07
Equity (Book Value)	9.56B
Book Value Per Share	42.63
Working Capital	2.16B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.69 billion and capital expenditures -437.95 million, giving a free cash flow of 1.26 billion.

Operating Cash Flow	1.69B
Capital Expenditures	-437.95M
Free Cash Flow	1.26B
FCF Per Share	5.60

Full Cash Flow Statement

Margins

Gross margin is 18.08%, with operating and profit margins of -5.32% and -6.81%.

Gross Margin	18.08%
Operating Margin	-5.32%
Pretax Margin	-9.67%
Profit Margin	-6.81%
EBITDA Margin	-1.58%
EBIT Margin	-5.32%
FCF Margin	7.52%

Dividends & Yields

NSE:NECLIFE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.02%
Shareholder Yield	n/a
Earnings Yield	-28.27%
FCF Yield	31.25%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 12, 2008. It was a forward split with a ratio of 10.

Last Split Date	Nov 12, 2008
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	4